tirzepatide danmark FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price Obesity drug seen as effective

Metabolic remodelling of the failing heart: the cardiac burn-out syndrome

Integration of GLP1 therapies into primary care pathways accelerates patient access, while public health campaigns elevate awareness of weightrelated health risks

47 The doses of semaglutide available for subcutaneous injection are 0.25 mg, 0.5 mg, 1 mg, or 2 mg for type 2 diabetes, and 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg for obesity, respectively

Here are a few signs to look out for if youre concerned someone you know is struggling with cannabis dependency: Using more cannabis or using it for longer periods than intended

From enhanced bioavailability to clinically proven ingredients, it's a supplement that delivers visible and lasting benefits

Nutritional status and hormonal balance should be assessed periodically